期刊文献+

胰体尾癌致脾梗塞及区域性门脉高压多层螺旋CT表现

Abnormal Splenic Vessels,Splenic Infarction and Secondary Segmental Portal Hypertension Invaded by Tumor of Body and Tail of Pancreas:Evaluation with Multi-Slice CT
下载PDF
导出
摘要 目的:探讨胰体尾癌累及脾血管并发脾梗塞及胰源性区域性门脉高压(PSPH)的多层螺旋CT(MSCT)表现及临床意义。方法:对28例胰体、尾癌患者进行增强多排螺旋CT血管成像(MSCTA)检查,并进行后处理重建显示脾动、静脉受侵情况及侧支循环。结果:28例均累及脾动脉,表现为脾动脉受压、推移、包绕征象,12例受压,16例被包绕,脾脏梗塞CT表现为三角形无强化的低密度灶。累及脾静脉致胰源性门脉高压中,胃左静脉、胃短静脉、胃网膜静脉、胃结肠干、食管下段静脉曲张或扩张的比例分别为68%、77%、85%、48%、7%,无脐静脉开放。结论:MSCT不仅能显示脾动脉受侵及脾梗塞情况,而且能显示脾静脉受阻致胰源性门脉高压侧支循环的分布和走行,在胰腺体尾癌术前分期和评估PSPH方面具有重要的临床意义。 Objective To investigate the multi -slice CT (MSCT) manifestation and clinical significance of collaterals in tumor of body and tail of pancreas invading splenic vessel leading to splenic infarction and pancreatogenic segmental portal hypertension( PSPH). Methods MSCT findings of tumor of body and tail of pancreas in 28 cases were retrospectively analyzed. The image was reconstruced to display the splenic artery and the pattern of collateral pathways. Results The splenic arteries were invaded in all 28 cases and was displaced or embed by the tumor, in which 12 cases were displacement and 16 cases were embed. The CT manifestation of splenic infarction was non - enhancement triangle location. In splenic vein occlusion cases, leading to pancreatogenie segmental potal hypertension, some veins varicosed or dilated, including gastric left vein (68%) , gastric short vein (77%) , gastroepiploic vein (85%), gastrocolic trunk (48%) ,and lower esophagus vein (7%) , but none of umbilical vein. Conclusion MSCT can not only demonstrate invaded splenic artery and splenic infarction, but also show characteristic anatomic distributions and pathways of PSPH. It is of clinical significance in preoperative staging of pancreatic tumors and evaluation of PSPH.
出处 《郧阳医学院学报》 2008年第2期132-136,共5页 Journal of Yunyang Medical College
关键词 胰腺肿瘤 脾血管 脾梗塞 门脉高压症 螺旋cT Pancreatic neoplasms Splenic vessel Splenic infarction Portal hypertension Spiral CT
  • 相关文献

参考文献10

二级参考文献29

  • 1Takase M, Suda K. Histopathological study on mechanism and background of tumor-forming pancreatitis. Pathol Int, 2001, 51: 349-354.
  • 2Lillemoe KD. Current management of pancreatic carcinoma. Ann Surg, 1995, 221: 133-148.
  • 3Fortner JC, Klimstra DS, Senie RT, et al. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Ann Surg, 1996, 223: 147-153.
  • 4Brennan MF. Pancreatic cancer. J Gastroenterol Hepatol, 2000, 15:13-16.
  • 5Buley ID. Update on special techniques in routine cytopathology. J Clin Pathol, 1993, 46:881-885.
  • 6Tada M, Ohashi M, Shiratori Y, et al. Analysis of K-ras gene mutation in hyperplastic duct cell of the pancreas without pancreatic disease. Gastroenterology, 1996, 110:227-231.
  • 7Hagluna C, Lundin J, Kuusrla P, et al. CA242, a new tumor marker for pancreatic cancer: a comparison with CA19-9, CA50 and CEA. Br J Cancer, 1994, 70:487-492.
  • 8Sandberg AA, Wagner M, Tihanyi T, et al. Technical aspects of left-sided pancreatic resection for cancer. Dig Surg, 1999, 16:305-312.
  • 9Rydberg J, Buckwalter KA, Caldemeyer KS, et al. Multisection CT: scanning techniques and clinical applications[J]. Radiographics, 2000,20(6):1787-1806.
  • 10Fishman EK. CT angiography: clinical applications in the abdomen[J]. Radiographics, 2001,21: S3-S16.

共引文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部